IBM aims to help pharmaceutical companies speed up digital transformation
The US technology giant IBM is using cutting-edge cloud computing technology to help Chinese pharmaceutical companies. Innovate their business processes and respond to the challenges posed by the COVID-19 pandemic.
One beneficiary is the Yangtze River Pharmaceutical Group. A China Pharmaceutical Group based in Taizhou City, Jiangsu Province, China.
Hua Honglian, director of the application system implementation department of the company’s information center, said that the pharmaceutical industry focuses on how to use technology to improve production efficiency. Furthermore, ensure product quality, control manufacturing costs, achieve drug traceability and support innovative research and development. .
Hua said: “We have been paying attention to technology trends and hope to speed up digital transformation.”
The company has deployed IBM’s cloud solution IBM Cloud Pak for Automation to achieve cross-organization, cross-department, cross-system, and cross-user business process automation.
Moreover, Xu Weijie, sales manager of IBM’s China Technology Group cloud computing and data platform business in East China and South China. Explain about the pandemic, many medical institutions did not need to accept digitalization.
However, the COVID-19 outbreak has changed this situation. Xu said they are aware of the importance of using digital technology to improve efficiency. When people cannot meet during a pandemic.
Unlike other industries where companies only need to consider efficiency, the medical industry needs to consider both efficiency and compliance requirements. Finally, Xu added that digital technology can help them meet these two needs.